Hong Kong DOH Updates the List of Refence Countries for Registration of Pharmaceutical Products
Hong Kong’s Pharmacy and Poisons Board reviewed the requirements of the list of reference countries for the registration of pharmaceutical …
Hong Kong Drug Office Publishes Frequently Asked Questions on Bioavailability and Bioequivalence Studies for Pharmaceutical Drugs
Hong Kong Drug Office has published a set of frequently asked questions on Phase 2 requirements of bioavailability (BA) and …
Hong Kong Drug Office Publishes Frequently Asked Questions for Clinical Trial Certificates
Hong Kong Drug Office has published a set of frequently asked questions on the application for clinical trial certificate (CTC) …
Hong Kong Drug Office Releases Guidance Notes on Classification of Products
Hong Kong Drug Office has published some guidance notes on the classification of products as “pharmaceutical products” in June 2022. …
Hong Kong Drug Office Updates Frequently Asked Questions’ Page
Hong Kong Drug Office has provided the latest set of frequently asked questions (FAQs) on their official website at the …
Hong Kong Drug Office Publishes Guideline on Pharmaceutical Products Recall
Hong Kong Drug Office has published some guidelines on the recall of pharmaceutical products in March 2022. Pharmaceutical products are …
Hong Kong Drug Office Publishes Guidance Notes on Registration of Pharmaceutical Products
Hong Kong Drug Office has published some guidance notes on the requirements of pharmaceutical products in February 2022. Registration of …
Hong Kong Drug Office Publishes Information on Requirement of Elemental Impurities Levels or Limits
Hong Kong Drug Office has published a guideline on the requirement of elemental impurities levels or limits in registered pharmaceutical …
Hong Kong Drug Office Publishes Latest Guidance for Import and Export Licences
Hong Kong Drug Office has published an updated guidance document for the application of import and export licences for pharmaceutical …
More News
#pharmaceuticalindustry
#regulatoryaffairs
ASEAN
Australia
Biologics/Biosimilars
Canada
China
Clinical Trials
Cosmetics
eCTD
EU
Global
Health Supplements
Herbal/Traditional Medicines
Hong Kong
India
Indonesia
Japan
Malaysia
Medical Devices
New Zealand
Pharmaceutical Drugs
Philippines
regulatory
Singapore
South Korea
Sri Lanka
Switzerland
Taiwan
Thailand
United Kingdom
United States
Vietnam